Carl Roos is a Senior Scientist at Novo Nordisk since November 2020, bringing expertise from previous roles as a Scientist in Clinical Pharmacology and PK/ADA Bioassay Coordinator at BioInvent International AB from January 2019 to November 2020. Carl holds a PhD from Uppsala University, where research focused on biopharmaceutical aspects of intestinal absorption and the effects of nanoformulations. Earlier experience includes a Summer Researcher position at AstraZeneca in 2012 and involvement in a Master Thesis project on inhalation formulations. Carl also participated as a Summer Research Student at Uppsala University, studying drug absorption and interactions with transport proteins. Educational qualifications include a Master of Science in Pharmaceutical Sciences from Uppsala University and academic experience at Leiden University.